Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02239494n
Noun Concept
Categories: Articles with short description, CYP3A4 inducers, Antineoplastic and immunomodulating drugs, Diarylketones, CYP1A2 inhibitors
EN
vemurafenib  ATC code L01XE15  ATCvet code QL01XE15  BRAF(V600E) Kinase Inhibitor RO5185426  N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide
EN
Vemurafenib, sold under the brand name Zelboraf, is a medication used for the treatment of late-stage melanoma. Wikipedia
Definitions
Relations
Sources
EN
Vemurafenib, sold under the brand name Zelboraf, is a medication used for the treatment of late-stage melanoma. Wikipedia
Chemical compound Wikidata
A drug for the treatment of late-stage melanoma. Wiktionary
IS A
compound
medicine
MEDICAL CONDITION TREATED
melanoma
skin cancer
hairy cell leukemia
Erdheim-Chester disease
PHYSICALLY INTERACTS WITH
c-Raf
PREGNANCY CATEGORY
Australian pregnancy category D
SUBJECT HAS ROLE
enzyme inhibitor
protein kinase inhibitor
antineoplastic
Wikipedia
EN
vemurafenib
Wikidata
EN
vemurafenib
Wiktionary
EN
vemurafenib
Wikipedia Redirections
EN
ATC code L01XE15, ATCvet code QL01XE15, PLX-4032, PLX4032, RG7204, RO5185426, Zelboraf
Wikidata Alias
EN
PLX4032, PLX 4032, RG7204, Vemurafenib, Zelboraf, Zelboraf®, BRAF(V600E) Kinase Inhibitor RO5185426, N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License